Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-027317
Filing Date
2020-02-07
Accepted
2020-02-07 06:24:33
Documents
4
Period of Report
2020-02-07

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d882696d6k.htm 6-K 10933
2 EX-99.1 d882696dex991.htm EX-99.1 14665
3 EX-99.2 d882696dex992.htm EX-99.2 220770
4 GRAPHIC g882696g0207095901483.jpg GRAPHIC 3155
  Complete submission text file 0001193125-20-027317.txt   251923
Mailing Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503
Business Address 2F, 3 YUANQU STREET NANGANG DISTRICT TAIPEI CITY F5 11503 886 2 2655 7377
Taiwan Liposome Company, Ltd. (Filer) CIK: 0001722890 (see all company filings)

IRS No.: 000000000 | State of Incorp.: F5 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38746 | Film No.: 20584480
SIC: 2834 Pharmaceutical Preparations